Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoapplication vs Bevacizumab Before Vitrectomy for PDR
NCT05514925Phase 4Unknown
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in proliferative diabetic retinopathy (PDR), Vitreous hemorrhage (VH) and Tractional retinal detachment (TRD) (2 arms). Primary endpoints: Total surgical time and Intraoperative bleeding. Status: unknown.
02
Conditions
proliferative diabetic retinopathy (PDR)Vitreous hemorrhage (VH)Tractional retinal detachment (TRD)
Beyond the preview
Go deeper on NCT05514925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514925.